Powder Stick Technology Strengthens CMO’s Position in Unit-Doses Market

Unither Pharmaceuticals is a world leader in BFS technology that enables preservative-free single-use doses manufacturing. Through its most recent pharmaceutical product launch, powder Unistick, the company reaffirms its expertise in the unit-doses and niche technologies market.

The powder Unistick is a niche pharmaceutical solution and an integral part of Unither’s mission to deliver reliable, competitive and sustainable products. The company established a dedicated workshop, equipped with powder-stick filling machine, at Unither Industries’ Gannat manufacturing plant, responding both to the technical and operational requirements necessary to obtain optimal efficiency.

Unither Industries’ workshops are specially designed for the manufacture of added-value dry forms. With dedicated air units and low humidity and temperature-controlled workshops, Unither Gannat manufactures effervescent tablets, lozenges, chewable tablets and orodispersible tablets on behalf of French and European pharmaceutical laboratories. Unither is committed to building its reputation for conception, development and manufacturing of added-value dry forms and powder Unistick’s arrival is proof of this.

The configuration of the stick-pack filling machine allows unit-doses performance that meets clients’ needs. In fact, the machine manufactures three sizes of stick-packs: 60, 80 and 120 mm. Every stick is designed to contain from 0.5 to 5 ml of powder. The machine is settled into a low humidity and temperature-controlled workshop. Consequently, the sticks can be filled with hydrophobic (effervescent or orodispersible) as well as conventional powders.

Light, nomadic and eco-friendly, as an alternative to conventional product forms (tablets, capsules, powder jars and sachets), Unistick is the lifecycle management solution to restore and revive pharmaceutical products on French and European markets.

Every Unither manufacturing plant now has an R&D and transfer platform. The company recently introduced the Coutances R&D team. Today, the Gannat R&D and transfer team provides the expertise in conception, development and industrial scale-up of added value dry forms. Some of the products developed by the Gannat R&D team are traded on the French and European markets, for example, Effervescent Paracetamol Unither 500 and 1000 mg. Currently, several orodispersible Unistick products are under development; new N-acetyl cysteine 200 mg powder stick will shortly enlarge Unither’s powder-stick family.

Where and when required, the Gannat team can rely on the galenic and analytical formulation expertise of colleagues from Unither Développement Bordeaux. In this way, Unither provides its clients both with exceptional ready-to-use solutions and outstanding R&D know-how, allowing them to receive a market tailored solution that meets patients’ needs.

Unither Pharmaceuticals, +33 1 44 63 51 70, www.unither-pharma.com.